Rahul Harkeri

Regenxbio (RGNX) reported Q4 EPS of ($1.38), $0.14 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $31.35 million versus the consensus estimate of...

Ignyta (RXDX) reported Q4 EPS of ($0.90), $0.01 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $650 thousand versus the consensus estimate of...

Oak Street Health (OSH) reported Q4 EPS of ($0.56), $0.04 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $577.7 million versus the consensus...

Khosla Ventures Acquisition Co. II (KIND) reported Q4 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $53.27 million versus the...

Myriad Genetics (NASDAQ:MYGN) reported Q4 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $177.8 million versus the...

Luxfer Holdings plc (NYSE:LXFR) reported Q4 EPS of $0.31, in-line with the analyst estimate of $0.31. Revenue for the quarter came in at $116.7 million versus the consensus...

Inter Parfums (NASDAQ:IPAR) reported Q4 EPS of $0.52, $0.23 better than the analyst estimate of $0.29. Revenue for the quarter came in at $311 million versus the consensus estimate...

Huron Consulting Group (NASDAQ:HURN) reported Q4 EPS of $1.12, $0.13 better than the analyst estimate of $0.99. Revenue for the quarter came in at $313.71 million versus the...

eXp World Holdings Inc. (NASDAQ:EXPI) reported Q4 EPS of $0.10, $0.08 better than the analyst estimate of $0.02. Revenue for the quarter came in at $933.4 million versus the...

Endeavor Group Holdings Inc. (EDR) reported Q4 EPS of ($0.72), $0.78 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $1.26 billion versus the consensus...